Rupatadine

drugbox
IUPAC_name = 8-chloro-6,11-dihydro-11-(1-((5-methyl-3-pyridyl)methyl)-
4-piperidylidene)-5"H"-benzo(5,6)cyclohepta(1,2-b)pyridine


CAS_number = 158876-82-5
ATC_prefix = R06
ATC_suffix = AX28
PubChem = 133017
DrugBank =
C = 26 | H = 26 | Cl = 1 | N = 3
molecular_weight = 415.958 g/mol
bioavailability =
protein_bound = 99%
metabolism = Hepatic, CYP-mediated
elimination_half-life = 5.9 hours
excretion = Fecal (60.9%) and renal (34.6%)
pregnancy_AU =
pregnancy_US =
pregnancy_category=
legal_AU =
legal_CA =
legal_UK =
legal_US =
legal_status =
routes_of_administration = Oral

Rupatadine is a new selective histamine H₁ receptor and platelet-activating factor (PAF) antagonist. Ruptatadine is marketed by Panacea-Biotech under the trade name Ralif. Ralif is approved for the treatment of allergic rhinitis.It can also be used for allergic urticaria.

External links

* [http://www.panacea-biotec.com/products/ralif.htm Product information]